An in-depth study of the CFTR gene enables selection of CFTR therapies for almost all individuals with CF
Pilot trial of tobramycin inhalation powder in cystic fibrosis patients with chronic Burkholderia cepacia complex infection
Bone demineralization is improved by ivacaftor in patients with cystic fibrosis carrying the p.Gly551Asp mutation
Evaluation of a systems biology approach to identify pharmacological correctors of the mutant CFTR chloride channel
Creation and characterization of an airway epithelial cell line for stable expression of CFTR variants